Product
SCRI-huCAR19v2
1 clinical trial
2 indications
Indication
LeukemiaIndication
lymphomaClinical trial
Pediatric and Young Adult Leukemia Adoptive Therapy (PLAT)-06: A Phase 1/2 Study of CD19-specific CAR T Cells With a Fully Human Binding Domain for CD19+ Leukemia or LymphomaStatus: Active (not recruiting), Estimated PCD: 2021-02-08